Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Anish Thomas
Woman and Man Max 99 years
Anish Thomas, M.D
Update Il y a 4 ans
Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Background: CRLX101 consists of a sugar molecule cyclodextrin linked to a chemotherapy drug called camptothecin. The combined molecule or nanoparticle drug conjugate travels through the bl...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Anish Thomas, M.D
Update Il y a 4 ans
Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Cancers
Background: Chemotherapy damages cancer cell DNA so the cells die and the tumor shrinks. But it may stop working in some people over time. This is partly due to efficient DNA damage repai...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Anish Thomas, M.D
Update Il y a 4 ans
A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies
Background: - Dimethane sulfonate (DMS612) is an investigational drug that is being administered to humans for the first time in people with advanced tumors. More information on t...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Anish Thomas
Update Il y a 4 ans
Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors
This phase I trial studies the side effects and best dose of veliparib when given together with liposomal irinotecan in treating patients with solid tumors. Liposomal irinotecan and velipa...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Anish Thomas, M.D
Update Il y a 4 ans
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
BACKGROUND: - The histone deacetylase (HDAC) inhibitors are a novel class of anticancer agent. These agents lead to the increased acetylation of both histone and non-histone prote...
Country
None
organs
None
Specialty
None
Closed trial
More information